Two of the lines enriched with MM909.24 overexpressing MR1*01 responded well to these targets but exhibited dependency on overexpressed MR1*01 for maximal reactivity, with minimal activation toward WT melanoma cells (Figure 1C). The gene discussed is MR1; the disease is melanoma.